Effectdossier · gearchiveerd kwartaal
KOD
Kodiak Sciences Inc. · Healthcare · Biotechnology
18Gevolgde houders
+2Δ houders
13.89MGehouden aandelen
$227.40MGerapporteerde waarde
+2Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +12.5% ·
aandelenstroom +12.1% ·
netto nieuwe posities +11.1%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +7 | 23.28M | $907.00M | +13 | −5 |
| Q1 2026 | 73 | +1 | 22.77M | $867.18M | +7 | −7 |
| Q4 2025 | 73 | 0 | 22.52M | $629.54M | +1 | — |
| Q3 2025 | 18 | +2 | 13.89M | $227.40M | +2 | — |
| Q2 2025 | 13 | 0 | 11.40M | $42.51M | +1 | −1 |
| Q1 2025 | 10 | +1 | 5.74M | $16.11M | +1 | — |
| Q4 2024 | 9 | -1 | 5.98M | $59.47M | +2 | −3 |
| Q3 2024 | 9 | +3 | 2.45M | $6.41M | +3 | — |
| Q2 2024 | 6 | — | 2.71M | $6.38M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 2.84M | +526.7% | $46.44M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 1.95M | +7.0% | $31.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 1.95M | +7.0% | $31.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 1.95M | +7.0% | $31.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 1.33M | -35.1% | $21.85M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passief) | 832.44K | -0.6% | $13.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 801.44K | +1.5% | $13.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 801.44K | +1.5% | $13.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 647.59K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 502.22K | +1202.4% | $8.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 502.22K | +1202.4% | $8.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 461.30K | -39.6% | $7.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 457.86K | -23.9% | $7.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 457.86K | -23.9% | $7.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 326.78K | — | $5.35M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Goldman Sachs Group ✦ | 326.78K | — | $5.35M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Fidelity (FMR) ✦ | 263.05K | +4.3% | $4.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 263.05K | +4.3% | $4.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | Millennium Management ✦ | 155.25K | Nieuw | $2.54M | 0.0% | New | 1 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 138.26K | +158.9% | $2.26M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | Wellington Management ✦ | 117.06K | +26.5% | $1.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | Wellington Management ✦ | 117.06K | +26.5% | $1.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Wellington Management ✦ | 117.06K | +26.5% | $1.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 45.45K | Nieuw | $744,098 | 0.0% | New | 1 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 41.17K | -27.3% | $674,003 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 41.17K | -27.3% | $674,003 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 41.17K | -27.3% | $674,003 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 41.17K | -27.3% | $674,003 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 41.17K | -27.3% | $674,003 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 26.39K | — | $431,970 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 26.39K | — | $431,970 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 26.39K | — | $431,970 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 26.39K | — | $431,970 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Millennium Management | $2.54M | 0.0% |
| Citadel Advisors | $744,098 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 186 houders, 57.91M aandelen, $2.09B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API